The 69 rating InvestorsObserver gives to Cerevel Therapeutics Holdings Inc (CERE) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 94 percent of stocks in the Biotechnology industry, CERE’s 69 overall rating means the stock scores better than 69 percent of all stocks.
CERE has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on CERE!